OrganiGram (NasdaqGS:OGI) Q1 2026 Earnings call February 10, 2026 08:00 AM ET Company ParticipantsGreg Guyatt - CFOJames Yamanaka - CEOMax Schwartz - Director of Investor RelationsPablo Zuanic - Managing DirectorConference Call ParticipantsAaron Grey - Research AnalystBrenna Cunnington - Research AnalystKenric Tyghe - Stock AnalystOperatorI will now hand the call over to Max Schwartz, Director of Investor Relations. Please go ahead.Max SchwartzVery much, Kara. Good morning, everyone. Thanks for joining us t ...

Investor Presentation December 31, 2025 CAUTIONARY STATEMENT This document is current as of December 31, 2025, except where otherwise stated. The information contained in this presentation is provided by Organigram Global Inc. ("Organigram" or the "Company") for informational purposes only and does not constitute an offer to issue or arrange to issue, or the solicitation of an offer to issue, securities of Organigram or other financial products. No part of this presentation shall form the basis or be relied ...

Industry Overview - The U.S. cannabis sector is evolving in early 2026, presenting both risks and opportunities for investors [1] - Regulatory uncertainty has shifted focus towards efficiency, balance sheet repair, and selective growth among operators [1][2] - Potential federal reforms could significantly reshape industry valuations, prompting investors to be more selective [1][2] Investment Focus - Traders are prioritizing companies with established market positions, improving cash flow, and scalable infrastructure [2] - Multi-state operators are expected to benefit from future regulatory changes, including federal tax treatment and banking access [2] Market Volatility - The cannabis market remains volatile, necessitating disciplined risk management [3] - Many stocks are trading below previous highs, creating opportunities for patient investors [3] - Weaker operators may face challenges if capital markets remain tight, emphasizing the importance of company selection [3] February 2026 Outlook - February 2026 is anticipated to be significant for the sector, influenced by earnings updates, regulatory news, and market sentiment [4] - Investors are looking for stocks that combine scale, brand strength, and improved financial discipline [4] Featured Companies AYR Wellness Inc. (AYRWF) - AYR Wellness is a vertically integrated operator with a growing national footprint, primarily in Florida and other states [6][8] - The company focuses on operational control across the supply chain, allowing adjustments based on market demand [9] - Recent restructuring efforts aim to strengthen liquidity and reduce financial strain, with a focus on cost control and cash flow trends [10][11] Cresco Labs Inc. (CRLBF) - Cresco Labs is a well-established multi-state operator with a strong presence in both medical and adult-use markets [12][14] - The company emphasizes brand consistency and consumer trust, with a dual approach of retail and wholesale operations [15] - Financially, Cresco generates high revenue totals, focusing on improving adjusted EBITDA and operating cash flow [16][17] Glass House Brands Inc. (GLASF) - Glass House Brands operates with a strong focus on California, utilizing large greenhouse facilities for cost-efficient production [18][20] - The company emphasizes operational efficiency and quality control through vertical integration [21] - Financial performance has been uneven due to market challenges, but increased production volumes and potential regulatory improvements could support future growth [22][23]

Core Insights - Gold prices remain steady above $5,000 per ounce amid geopolitical and economic risks, with predictions of potential increases to $6,000 due to a weaker dollar [1] - Consumer staples are highlighted as a defensive sector that can protect capital during market volatility, offering steady dividend income and reliable revenue [1] Consumer Staples Sector - Consumer staples are considered a 'safe' sector as they sell essential goods, leading to predictable revenue streams [1] - These companies typically have steady dividend income, reliable earnings, and the ability to pass on rising costs to consumers [1] - Low beta characteristics of consumer staples stocks make them less volatile compared to the broader market, appealing to institutional investors during turbulent times [1] Featured Consumer Staples Stocks 1. Waste Management - Waste Management Inc. has a near-monopoly in many locations due to its extensive landfill network, making it a strong dividend payer with a 52% dividend payout rate and a 22-year history of annual increases [1] - The stock is experiencing a bullish trend, having surpassed the 200-day simple moving average for the first time since last September [1] 2. British American Tobacco - British American Tobacco plc has shifted towards smokeless products, maintaining a dividend yield of over 5% with a 63% dividend payout ratio [1] - The stock has returned nearly 60% in the last 12 months and shows potential for further gains following a period of consolidation [1] 3. Service Corporation International - Service Corporation International Inc. is the largest provider of funeral and cemetery services in North America, benefiting from an aging population [1] - The company has a dividend yield of 1.68% with a 36.7% payout ratio, and it has raised its dividend for 15 consecutive years [1] - The company raised its 2025 cash flow guidance to between $915 million and $950 million, supporting future payout increases [2]

Core Insights - Canopy Growth's stock is trading at less than $2, raising questions about its attractiveness as an investment given the current market conditions [1] Group 1: Market Performance - Canopy Growth is one of the largest cannabis producers in Canada, with a diverse product portfolio including dried cannabis, vapes, and cannabis-infused drinks [3] - The Canadian cannabis market has been disappointing, with limited growth opportunities, significant competition, and ongoing legal and regulatory challenges affecting all Canadian cannabis companies [4] - The overall cannabis industry in Canada has experienced slow revenue growth and consistent net losses, indicating systemic issues rather than company-specific problems [5] Group 2: U.S. Market Dynamics - Recent developments in the U.S. cannabis market, such as the reclassification of cannabis by President Trump, may improve conditions for U.S. cannabis companies but are unlikely to benefit Canopy Growth significantly [5][6] - Cannabis remains illegal at the federal level in the U.S., creating challenges for companies, including high operational costs and difficulties in profitability [7] - Canopy Growth's U.S. subsidiary will face intense competition, similar to what it experiences in Canada, limiting its potential for recovery [7]

Financial Data and Key Metrics Changes - In Q4, net revenue increased 79% to CAD 80.1 million from CAD 44.7 million in the same prior year period [16] - Full-year fiscal 2025 net revenue increased 62% to CAD 259.2 million from CAD 159.8 million in the prior year [16] - Adjusted gross profit for Q4 increased 85% to CAD 30.6 million versus CAD 16.5 million in Q4 last year [18] - Adjusted EBITDA set a company record in fiscal 2025, with Q4 adjusted EBITDA of CAD 9.8 million, an increase of 72% sequentially and 69% year-over-year [23] - The net loss for Q4 was CAD 38 million, compared to a net loss of CAD 5.4 million in the same prior year period [25] Business Line Data and Key Metrics Changes - The acquisition of Motif Labs contributed significantly to growth without market share dilution [4] - International sales reached a record CAD 26.3 million, a 171% increase versus the prior year [10][17] - The company achieved a 35% adjusted gross margin for the full year, a 100 basis point increase from last year [18] Market Data and Key Metrics Changes - The company holds the number one market position in Canada with an 11.9% market share in fiscal 2025 [7] - Market share in New Brunswick reached 34.2%, 23.7% in Newfoundland, 14.9% in Saskatchewan, and 12.2% in Nova Scotia [8] - The company experienced a temporary market share impact in Q1 due to a strike affecting large LPs in British Columbia [10] Company Strategy and Development Direction - The company aims to increase the margin profile of its domestic product mix while optimizing operational footprint for capacity and throughput [9] - Plans to launch new products, including coated infused pre-rolls and beverages, are in place to meet evolving consumer needs [9] - The company is focused on disciplined execution and sustainable growth, with an emphasis on margin expansion and international growth [15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in continued growth supported by a stronger platform and expanding international opportunities [29] - The company is monitoring regulatory changes in the U.S. that could impact its business but does not expect a material adverse economic impact [12] - Management anticipates strong net revenue growth exceeding CAD 300 million in fiscal 2026, along with further improvements in adjusted gross margin and adjusted EBITDA [27] Other Important Information - The company received a CAD 2 million grant from Opportunities New Brunswick to support facility enhancements [6] - The Jupiter Fund currently has CAD 59 million available for deployment to leverage opportunities in markets outside of Canada [13] - The company is awaiting a determination on its EU-GMP application, which could positively impact its international business [12] Q&A Session Summary Question: International growth expectations and supply-demand dynamics - Management indicated that they are starting to realize increased capacity and are well-positioned for fiscal 2026, particularly in Germany [34] Question: Gross margin expectations for fiscal 2026 - Management expects gross margins to improve, driven by operational improvements and synergies from the Motif acquisition [38] Question: Margin improvement sources - The majority of margin improvement is expected to come from operational improvements in cultivation rather than solely from Motif synergies [48] Question: CapEx plans for the next year - The company plans to keep capital expenditures modest for fiscal 2026, with expectations to spend less than CAD 10 million [49]

Sales of vapes, cigarettes and other tobacco products slumped more than any other grocery category in the UK, a survey showed, a sign that tighter regulations and health concerns are curbing smoking habits https://t.co/xgfED1x6c8 ...

Industry Overview - The U.S. cannabis industry is projected to approach $45 billion by 2025, driven by increasing demand for both medical and recreational use as more states expand access [1] - Marijuana penny stocks are gaining popularity due to their potential for sharp gains and quick movements, especially with recent optimism surrounding possible federal rescheduling [1][2] AYR Wellness Inc. (AYRWF) - AYR Wellness is a multi-state operator with a strong presence in Florida, operating over 70 dispensaries across the U.S. and focusing on both medical and recreational markets [3][5] - The company is recognized for its commitment to customer experience, product consistency, and strong branding, positioning itself as a developing leader among penny-level operators [3][6] - Recent financial performance shows stable revenue, with a focus on cost reduction and operational improvements to support sustainable profitability [5][6] Cansortium Inc. (CNTMF) - Cansortium operates under the Fluent brand, primarily in Florida, with over 30 dispensaries and a focus on high-quality medical products [7][10] - The company emphasizes operational efficiency and has streamlined its operations to improve gross margins and cash flow [10] - Despite facing regulatory costs and market saturation, Cansortium's controlled growth strategy and expanding patient network provide significant upside potential [10] Verano Holdings Corp. (VRNO) - Verano is a major multi-state operator with over 130 dispensaries, known for its premium brands and vertically integrated infrastructure [11][12] - The company has invested heavily in cultivation and manufacturing, ensuring reliable product quality and a diverse product lineup [12][13] - Recent financial performance indicates revenue growth driven by rising consumer adoption, although regulatory costs continue to pressure net profits [15]

Group 1: Honeywell - Honeywell declared a 5% increase in its quarterly dividend, raising it to $1.19 per share [4] - The company is undergoing a significant transition, splitting into three separate entities: Solstice Advanced Materials, Honeywell Automation, and Honeywell Aerospace, with the first split expected by the end of this year [5] - In its last reported quarter as a single entity, Honeywell achieved an 8% year-over-year revenue growth, reaching $10.4 billion, while GAAP net income increased marginally to almost $1.6 billion [6] - The company raised its revenue and profitability guidance for full-year 2025, driven by high demand for aerospace components and maintenance offerings [7] - The new dividend will be paid on December 5 to investors of record as of November 14, yielding just under 2.3% at the most recent closing share price [8] Group 2: Philip Morris International - Philip Morris International announced a 9% increase in its quarterly dividend, raising it to $1.47 per share, continuing its streak of annual dividend raises since 2009 [10] - The company reported a 15% year-over-year increase in sales of its "smoke-free" products, totaling $4.2 billion, while traditional cigarette sales rose by 2% to $6 billion, leading to total revenue of over $10 billion, a 7% gain [12] - Net income saw a significant boost of 25%, exceeding $3.1 billion, prompting management to raise bottom-line guidance for 2025 [13] - Despite the positive results, there is concern as cigarette shipments declined by 1.5%, indicating potential challenges in maintaining growth from traditional products [14] - The enhanced dividend is set to be paid on October 20 to stockholders of record as of October 3, yielding a theoretical 3.6% at the current share price [15]

High Tide Conference Call Summary Company Overview - **Company Name**: High Tide (NasdaqCM: HITI) - **Ticker**: HITI on NASDAQ since 2021 and TSX Venture Exchange since 2018 - **Main Operating Company**: Canna Cabana, the largest retail cannabis brand in Canada with over 207 stores [2][3] Financial Performance - **Trailing Revenue**: Approximately CAD 683 million, including recent acquisitions [2] - **Adjusted EBITDA**: CAD 58 million, with a pro forma trailing adjusted EBITDA multiple of 8.8 times [3] - **Same-Store Sales Growth**: Up 137% since October 2021, compared to a 2% decline for peers [4][14] - **Market Share**: 12% in the five provinces of operation, with a target to reach 15% [4][15] - **Revenue per Square Foot**: CAD 1,735, outperforming many blue-chip retailers [5][16] - **Free Cash Flow**: Generated CAD 4 million in July 2023, five months ahead of schedule [25][26] Recent Developments - **Acquisition**: Acquired 51% of Ramexian Pharma, a leading medical cannabis importer in Germany, for €26.4 million [19] - **Market Expansion**: Entering the German market, which has seen a significant increase in patient counts from 250,000 to 900,000 [20][21] - **Growth in German Cannabis Imports**: Annualized imports increased from CAD 30-40 million to CAD 300 million post-reclassification of medical cannabis [23] Strategic Insights - **Retail Strategy**: Focus on smaller, efficient store sizes (1,200 to 1,500 square feet) rather than larger stores [9][18] - **Loyalty Program**: 2.15 million loyalty members, with 115,000 ELITE members paying CAD 35 annually for additional discounts [4][12] - **Consumer Preferences**: Pre-rolls and dried flower account for about two-thirds of sales, with vapes at 22% [7][8] Market Context - **Canadian Cannabis Market**: Legalized in October 2018, now a CAD 5.5 billion market, with Canna Cabana's operations in a CAD 4.5 billion retail market [6] - **Competitive Landscape**: Canna Cabana's average store revenue significantly exceeds that of peers, with Alberta stores averaging CAD 2.3 million and Ontario stores over CAD 3.1 million [14][15] Future Outlook - **Store Growth**: Targeting to exceed 300 stores, with plans to open 20-30 new stores annually [27] - **Vertical Integration**: Exploring opportunities in cannabis accessories and white-label products, though full vertical integration is limited by regulations [34][36] - **International Expansion**: Monitoring other European markets (UK, Poland, Czech Republic, Switzerland) for potential entry [32] Key Takeaways - High Tide is positioned as a leading innovative retailer in the cannabis space, with strong financial metrics and growth potential in both Canada and Germany [41] - The company is leveraging its retail relationships to capitalize on the growing medical cannabis market in Germany, aiming for significant market share [42]